The Harvard-Mass General Brigham (MGB) Dermatopathology Fellowship is an ACGME-accredited training program that draws on the facilities of the Brigham and Women's Hospital (BWH) and Massachusetts General Hospital (MGH), with didactic input from faculty at Boston Children's Hospital and the Dana-Farber Cancer Institute. The Harvard Fellowship is overseen at BWH by Dr. George Murphy, Program Director and Dr. Alvaro Laga, Co-Director, and at MGH by Dr. Mai Hoang, Institutional Director.
The period of fellowship is one year. Fellows enter the program eligible for Board certification in dermatology or pathology and receive training in the complementary fields of anatomic pathology or clinical dermatology, respectively. Additionally, fellows receive training in immunopathology, immunofluorescence, microbiology/mycology, tissue processing for both routine and specialized microscopy, diagnostic electron microscopy, immunohistochemistry, molecular genomics, and laboratory management. The program uniquely in provides rotational exposure to two major Harvard teaching hospitals (MGB), exposing fellows with a wide range of faculty expertise and institutional resources.
Clinical and translational research opportunities are available throughout the program, and at least one research project is required. Fellows have abundant opportunities to attend a wide variety of clinical and pathological-diagnostic conferences, and are required to teach in training programs offered to residents and medical students.
The MGB Diagnostic Services analyze daily a large number of diverse and complex specimens derived from Mass General and Brigham clinical practices as well as the Dana-Farber Cancer Institute. The Services are supported by comprehensive special diagnostic laboratories that provide a vast array of immunohistochemical and molecular probes. The Research Divisions occupy a complementary facility conducting NIH-funded investigation focused on molecular and cellular pathways responsible for cutaneous cytotoxicity, melanocyte/melanoma stem cell biology, skin cancer and transplantation immunology, epigenetics, and proteasome/ubiquitin biology. Thus there exist ample resources for participation in translational research that complements acquisition of basic diagnostic skills requisite for dermatopathology practice and/or for academic careers as clinical educators and physician/scientists.
Faculty mentors are actively involved in didactic initiatives, including authorship participation in a number of dermatopathology texts, including recent editions of Pathology of the Skin, and Lever's Histology of the Skin, and the AFIP Fascicles on Melanocytic Tumors of the Skin and Inflammatory Disorders of the Skin.
Fellowship candidates must be graduates of approved medical schools in the United States or Canada. Graduates of foreign medical schools must have an ECFMG Certificate. Applicants must have completed a residency training program in either Pathology or Dermatology and be eligible for certification in either one to enter the program. We will begin accepting applications on July 1, 2024 for academic year 2026-2027.
Applications to the Dermatopathology Fellowship for AY 2026-2027 need to be submitted with the following information:
Fellowship application form and inquiries should be submitted by email to:
Department of Pathology
Brigham and Women's Hospital
75 Francis Street
Boston, MA 02115
More information for prospective applicants can be found on our GME website
For over a century, a leader in patient care, medical education and research, with expertise in virtually every specialty of medicine and surgery.